Systemic anticoagulation is associated with decreased mortality and morbidity in acute pancreatitis.
暂无分享,去创建一个
M. Wallace | M. Raimondo | B. Ji | Yaohua Ma | S. Antwi | P. T. Kröner | Y. Bi | Zhuo-xing Li | P. Kröner
[1] B. Baysal,et al. Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled,open-label study. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[2] Ying Wang,et al. Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H. , 2019, The Journal of clinical investigation.
[3] C. Thongprayoon,et al. Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013–2014 , 2019, Lung.
[4] P. Hart,et al. The Changing Epidemiology of Acute Pancreatitis Hospitalizations: A Decade of Trends and the Impact of Chronic Pancreatitis , 2017, Pancreas.
[5] Jennifer L. Lund,et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. , 2015, Gastroenterology.
[6] R. Carnahan,et al. A systematic review of validated methods for identifying pancreatitis using administrative data , 2012, Pharmacoepidemiology and drug safety.
[7] T. Uchida,et al. Antithrombin III Prevents Cerulein-Induced Acute Pancreatitis in Rats , 2009, Pancreas.
[8] D. Radenkovic,et al. d-Dimer in Acute Pancreatitis: A New Approach for an Early Assessment of Organ Failure , 2009, Pancreas.
[9] Zhang Kai-cheng,et al. Low Molecular Weight Heparin in the Treatment of Severe Acute Pancreatitis: A Multiple Centre Prospective Clinical Study , 2009 .
[10] S. Konturek,et al. Protective and therapeutic effect of heparin in acute pancreatitis. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[11] C. Camargo,et al. Increasing United States hospital admissions for acute pancreatitis, 1988-2003. , 2007, Annals of epidemiology.
[12] D. Yadav,et al. Trends in the Epidemiology of the First Attack of Acute Pancreatitis: A Systematic Review , 2006, Pancreas.
[13] Masahiko Hirota,et al. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis , 2006, Journal of Gastroenterology.
[14] Y. Takeyama,et al. Elevation of plasma tissue factor levels in patients with severe acute pancreatitis , 2006, Journal of Gastroenterology.
[15] M. Ohmuraya,et al. Applicability of Disseminated Intravascular Coagulation Parameters in the Assessment of the Severity of Acute Pancreatitis , 2006, Pancreas.
[16] C. Hack,et al. Protective effect of antithrombin III in acute experimental pancreatitis in rats , 1992, Digestive Diseases and Sciences.
[17] D. Radenkovic,et al. Disorders of Hemostasis During the Surgical Management of Severe Necrotizing Pancreatitis , 2004, Pancreas.
[18] L. Gullo,et al. Coagulative Disorders in Human Acute Pancreatitis: Role for the D-Dimer , 2003, Pancreas.
[19] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[20] J. Schölmerich,et al. lnterleukin‐8 and neutrophil activation in acute pancreatitis , 1992, European journal of clinical investigation.
[21] M. Büchler,et al. Ultrastructure of human acute pancreatitis , 1986, International journal of pancreatology : official journal of the International Association of Pancreatology.
[22] K. Ohlsson,et al. Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. , 1986, Thrombosis research.
[23] A. Aasen,et al. Studies on pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report. , 1982, Acta chirurgica Scandinavica. Supplementum.